This is similar to what is observed in tumour-naïve Fgl2−/− mice with greater expression of co-stimulatory marker (CD86+) (Fig. S7K), as previously reported5, suggesting more antigen presentation in the periphery. This evidence concerns the gene CD86 and neoplasm.